GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Aosaikang Pharmaceutical Co Ltd (SZSE:002755) » Definitions » EV-to-FCF

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) EV-to-FCF : 57.22 (As of Apr. 23, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Aosaikang Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Beijing Aosaikang Pharmaceutical Co's Enterprise Value is ¥15,839 Mil. Beijing Aosaikang Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥277 Mil. Therefore, Beijing Aosaikang Pharmaceutical Co's EV-to-FCF for today is 57.22.

The historical rank and industry rank for Beijing Aosaikang Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

SZSE:002755' s EV-to-FCF Range Over the Past 10 Years
Min: -1187.49   Med: 26.45   Max: 476.22
Current: 55.28

During the past 13 years, the highest EV-to-FCF of Beijing Aosaikang Pharmaceutical Co was 476.22. The lowest was -1187.49. And the median was 26.45.

SZSE:002755's EV-to-FCF is ranked worse than
77.66% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.31 vs SZSE:002755: 55.28

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-23), Beijing Aosaikang Pharmaceutical Co's stock price is ¥18.43. Beijing Aosaikang Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.180. Therefore, Beijing Aosaikang Pharmaceutical Co's PE Ratio (TTM) for today is 102.39.


Beijing Aosaikang Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Beijing Aosaikang Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Aosaikang Pharmaceutical Co EV-to-FCF Chart

Beijing Aosaikang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.51 28.09 23.39 -28.86 -54.63

Beijing Aosaikang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.24 -54.63 66.75 35.22 33.18

Competitive Comparison of Beijing Aosaikang Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Aosaikang Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Aosaikang Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Aosaikang Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Beijing Aosaikang Pharmaceutical Co's EV-to-FCF falls into.


;
;

Beijing Aosaikang Pharmaceutical Co EV-to-FCF Calculation

Beijing Aosaikang Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=15839.442/276.805
=57.22

Beijing Aosaikang Pharmaceutical Co's current Enterprise Value is ¥15,839 Mil.
Beijing Aosaikang Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥277 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Aosaikang Pharmaceutical Co  (SZSE:002755) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Beijing Aosaikang Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18.43/0.180
=102.39

Beijing Aosaikang Pharmaceutical Co's share price for today is ¥18.43.
Beijing Aosaikang Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.180.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Beijing Aosaikang Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Beijing Aosaikang Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Aosaikang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
South Fourth Ring Road, Building 28 , 7th District, No. 188, Fengtai District, Beijing, CHN, 100070
Beijing Aosaikang Pharmaceutical Co Ltd is engaged in the research and development of domestic high-end first imitation drugs, chemical drugs, and biological drugs. Its products focus on digestion, tumors, drug-resistant infections, and chronic diseases.
Executives
Wang Zheng Yong Executives
Li Xiao Xin Supervisors
Ren Wei Rong Directors, executives
Chen Qing Cai Directors, Directors, and Executives
Du Chao Yang Executives
Ma Yao Chuan Director
Wu Zhan Feng Supervisors
Guo Hong Jie Director

Beijing Aosaikang Pharmaceutical Co Headlines

No Headlines